PeptiDream Inc. (TYO:4587)
1,481.00
+70.50 (5.00%)
At close: Mar 6, 2026
PeptiDream Market Cap
PeptiDream has a market cap or net worth of 191.37 billion as of March 6, 2026. Its market cap has decreased by -24.34% in one year.
Market Cap
191.37B
Enterprise Value
179.72B
Revenue
18.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,481.00
Market Cap Chart
Since June 11, 2013, PeptiDream's market cap has increased from 74.10B to 191.37B, an increase of 158.27%. That is a compound annual growth rate of 7.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 191.37B | -10.59% |
| Dec 30, 2025 | 214.04B | -37.55% |
| Dec 30, 2024 | 342.76B | 77.91% |
| Dec 29, 2023 | 192.66B | -28.55% |
| Dec 30, 2022 | 269.66B | -18.39% |
| Dec 30, 2021 | 330.41B | -49.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 165.62B |
| SanBio Company | 152.24B |
| Takara Bio | 138.00B |
| Nxera Pharma | 80.09B |
| Oncolys BioPharma | 75.97B |
| Cuorips | 56.45B |
| Healios K.K. | 54.27B |
| Japan Tissue Engineering | 28.14B |